Mirum Pharmaceuticals, Inc.

MIRM · Nasdaq · SIC 2834: Pharmaceutical Preparations
121
SEC Filings

Business Summary

EX-23.1 4 mirm-10k20251231xexx231.htm EX-23.1 Document Exhibit 23.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the following Registration Statements (1) Registration Statement (Form S-3 No. 333-265210) of Mirum Pharmaceuticals, Inc. (2) Registration Statement (Form S-3 No. 333-274973) of Mirum Pharmaceuticals, Inc. (3) Registration Statement (Form S-3 No. 333-289525) of Mirum Pharmaceuticals, Inc. (4) Registration Statement (Form S-8 ...

Next Earnings

Q2 FY2026 — expected 2026-08-06

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMIRMdiscussed_in_filing Healthcare & Bio
topic_mentionMIRMdiscussed_in_filing Healthcare & Bio
topic_mentionMIRMdiscussed_in_filing Healthcare & Bio
topic_mentionMIRMdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-252025-12-310001759425-26-000013EDGAR107K words
2025-02-262024-12-310001759425-25-000014EDGAR—
2024-03-152023-12-310000950170-24-032289EDGAR—
2023-03-082022-12-310000950170-23-006715EDGAR—
2022-03-092021-12-310000950170-22-003229EDGAR—
2021-03-092020-12-310001564590-21-011756EDGAR—
2020-03-122019-12-310001564590-20-010471EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001759425-25-000054EDGAR68K words
2025-08-062025-06-300001759425-25-000041EDGAR—
2025-05-072025-03-310001759425-25-000032EDGAR—
2024-11-122024-09-300001759425-24-000038EDGAR—
2024-08-072024-06-300001759425-24-000031EDGAR—
2024-05-082024-03-310001759425-24-000019EDGAR—
2023-11-022023-09-300000950170-23-058228EDGAR—
2023-08-072023-06-300000950170-23-038716EDGAR—
2023-05-042023-03-310000950170-23-017879EDGAR—
2022-11-092022-09-300000950170-22-023519EDGAR—
2022-08-042022-06-300000950170-22-014799EDGAR—
2022-05-052022-03-310000950170-22-007812EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-250001759425-26-000010EDGAR4K words
2026-01-260001193125-26-022582EDGAR—
2026-01-120001759425-26-000004EDGAR—
2025-12-190001193125-25-326822EDGAR—
2025-12-190001193125-25-325825EDGAR—
2025-12-080001193125-25-310611EDGAR—
2025-11-170001759425-25-000057EDGAR—
2025-11-040001759425-25-000053EDGAR—
2025-08-060001759425-25-000040EDGAR—
2025-05-300001759425-25-000034EDGAR—

121 total filings indexed. 92 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001759425
TickerMIRM
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 20680e112392f9d5b0ed3fd56c7a2685ae2f4f847940e01441ec42e23fa5a702
parent: fc6589fd8ea687998e712b48328c77cee542deb7cf3476def6326a81831340fb
content hash: 57c709d68749bf4e3425b9e1e9e7d394adfc4bc15ede768bcdeaab49ef2f0277
signed: 2026-04-13T04:46:16.567Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf